Krems Bioanalytics

Leading expertise in immunology, hematology, and oncology.

Krems Bioanalytics is a contract research institute providing cutting-edge bioanalytical services in the fields of immunology, hematology, and oncology since 2014. We have a long-standing expertise in the development and validation of customised and GxP compliant analytical assays for large molecules and vaccines. We offer sample analytics for early and late preclinical studies (R&D or GLP) and for clinical trials (GCP).

From a small team to a leading bioanalytical powerhouse

Established in 2014, the journey of Krems Bioanalytics exemplifies an unwavering dedication to growth, innovation, and staying at the forefront of bioanalytical research and services in the pharmaceutical field. With a remarkable transformation from a small team of 5 to a workforce of over 40, Krems Bioanalytics has evolved into a comprehensive bioanalytical service provider for the pharmaceutical sector supporting the entire drug development process – from preclinical stages to clinical development and post-market authorisation studies.

From immunogenicity to comprehensive bioanalytical services

In tandem with these substantial leaps, Krems Bioanalytics has significantly broadened its service repertoire. Initially focused on immunogenicity assessment, Krems Bioanalytics now encompasses a diverse range of analyses. This spans from crucial pharmacokinetic (PK) analysis to complex cell based biopotency assays, a testament to our expanded expertise.

Researchers from the IMC Bioanalytics Institute in front of a poster and bar table
A laboratory worker in protective clothing operates a BD FACSLyric laboratory device.

Introducing mass spectrometry as a key focus

Notably, the addition of cutting-edge mass spectrometry as a new focus point in 2021 signifies the institute’s ongoing innovation. Headed by an esteemed international expert, this development opens avenues for enhanced scientific inquiry, particularly in evaluating clinical effectiveness and adverse effects of biotherapeutics and vaccines.

Your Partner For Customised Bioanalytical Solutions.

Read more

Experience the best of both worlds

As a university-based contract research organisation (CRO), we are uniquely positioned to bridge the gap between cutting-edge research and pharmaceutical drug development. The university’s resources, such as its facilities and expertise, can be utilised to provide a strong foundation for preclinical and clinical development. We can leverage these resources to conduct research and development in a quality environment necessary for regulatory approval.

A partnership with Krems Bioanalytics opens doors to public funding, innovative technology, and expertise from academia and industry. With our expertise, state-of-the-art facilities, and commitment to quality, we are the ideal partner for those seeking to accelerate their drug development programmes and bring new therapeutics to market.

Our mission is to provide bioanalytical data at the highest standards to support preclinical and clinical drug development.

Christian Lubich

Head of Institute / Institute Krems Bioanalytics

Services & Contact

Institute Krems Bioanalytics

If you have any questions, just send us an e-mail to office(at)krems-bioanalytics.com.

You can find an overview of our services on our website.

Services at a glance